বাংলায় দেখুন
Scabo

Scabo

Tablet

🧬 Ivermectin 🏢 Delta Pharma Ltd.
Generic Name Ivermectin
Manufacturer Delta Pharma Ltd.
Unit Price Unit Price: ৳ 5.00 (2 x 10: ৳ 100.00) Strip Price: ৳ 50.00

🔹 Indications

Scabo tablet is indicated for the treatment of-
  • Strongyloidiasis
  • Onchocerciasis
  • Filariasis
  • Scabies &
  • Head lice.
Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Scabo.

Onchocerciasis: Scabo is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).

🔹 Pharmacology

Scabo tablet is indicated for the treatment of-
  • Strongyloidiasis
  • Onchocerciasis
  • Filariasis
  • Scabies &
  • Head lice.
Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Scabo.

Onchocerciasis: Scabo is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).

🔹 Dosage & Administration

Scabo tablet is indicated for the treatment of-
  • Strongyloidiasis
  • Onchocerciasis
  • Filariasis
  • Scabies &
  • Head lice.
Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Scabo.

Onchocerciasis: Scabo is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).

🔹 Interaction

Scabo tablet is indicated for the treatment of-
  • Strongyloidiasis
  • Onchocerciasis
  • Filariasis
  • Scabies &
  • Head lice.
Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Scabo.

Onchocerciasis: Scabo is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).

🔹 Contraindications

Scabo tablet is indicated for the treatment of-
  • Strongyloidiasis
  • Onchocerciasis
  • Filariasis
  • Scabies &
  • Head lice.
Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Scabo.

Onchocerciasis: Scabo is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).

🔹 Side Effects

Scabo tablet is indicated for the treatment of-
  • Strongyloidiasis
  • Onchocerciasis
  • Filariasis
  • Scabies &
  • Head lice.
Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Scabo.

Onchocerciasis: Scabo is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).

🔹 Pregnancy & Lactation

Scabo tablet is indicated for the treatment of-
  • Strongyloidiasis
  • Onchocerciasis
  • Filariasis
  • Scabies &
  • Head lice.
Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Scabo.

Onchocerciasis: Scabo is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).

🔹 Precautions & Warnings

Scabo tablet is indicated for the treatment of-
  • Strongyloidiasis
  • Onchocerciasis
  • Filariasis
  • Scabies &
  • Head lice.
Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis. This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of Scabo.

Onchocerciasis: Scabo is indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus. This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).

💡 Frequently Asked Questions

Scabo tablet is indicated for the treatment of- Strongyloidiasis Onchocerciasis Filariasis Scabies & Head lice. Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal ... Read moreScabo tablet is indicated...
Scabo tablet is indicated for the treatment of- Strongyloidiasis Onchocerciasis Filariasis Scabies & Head lice. Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal ... Read moreScabo tablet is indicated...
Scabo tablet is indicated for the treatment of- Strongyloidiasis Onchocerciasis Filariasis Scabies & Head lice. Strongyloidiasis of the intestinal tract: Scabo is indicated for the treatment of intestinal ... Read moreScabo tablet is indicated...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review